Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP100154.RALRtSbgCdMYMyRMahb5BU7j7T6lQ_BR3RdGgQAMmdgUc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP100154.RALRtSbgCdMYMyRMahb5BU7j7T6lQ_BR3RdGgQAMmdgUc130_assertion type Assertion NP100154.RALRtSbgCdMYMyRMahb5BU7j7T6lQ_BR3RdGgQAMmdgUc130_head.
- NP100154.RALRtSbgCdMYMyRMahb5BU7j7T6lQ_BR3RdGgQAMmdgUc130_assertion description "[Among the glassy cell carcinoma (GCC) cases, estrogen receptor (ER), progesterone receptor (PR) and Her2/neu were positive in 2 (18.1%), 1 (9.1%) and 5 (45.4%) cases, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100154.RALRtSbgCdMYMyRMahb5BU7j7T6lQ_BR3RdGgQAMmdgUc130_provenance.
- NP100154.RALRtSbgCdMYMyRMahb5BU7j7T6lQ_BR3RdGgQAMmdgUc130_assertion evidence source_evidence_literature NP100154.RALRtSbgCdMYMyRMahb5BU7j7T6lQ_BR3RdGgQAMmdgUc130_provenance.
- NP100154.RALRtSbgCdMYMyRMahb5BU7j7T6lQ_BR3RdGgQAMmdgUc130_assertion SIO_000772 16901007 NP100154.RALRtSbgCdMYMyRMahb5BU7j7T6lQ_BR3RdGgQAMmdgUc130_provenance.
- NP100154.RALRtSbgCdMYMyRMahb5BU7j7T6lQ_BR3RdGgQAMmdgUc130_assertion wasDerivedFrom lhgdn-20090331 NP100154.RALRtSbgCdMYMyRMahb5BU7j7T6lQ_BR3RdGgQAMmdgUc130_provenance.
- NP100154.RALRtSbgCdMYMyRMahb5BU7j7T6lQ_BR3RdGgQAMmdgUc130_assertion wasGeneratedBy ECO_0000203 NP100154.RALRtSbgCdMYMyRMahb5BU7j7T6lQ_BR3RdGgQAMmdgUc130_provenance.